Literature DB >> 1802563

Pharmacokinetics of imipenem/cilastatin during continuous arteriovenous hemofiltration.

M Przechera1, D Bengel, T Risler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1802563     DOI: 10.1159/000420202

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  7 in total

1.  Using imipenem and cilastatin during continuous renal replacement therapy.

Authors:  Alison Cotton; Bryony Dean Franklin; Stephen Brett; Alison Holmes
Journal:  Pharm World Sci       Date:  2005-10

Review 2.  Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations.

Authors:  P Reetze-Bonorden; J Böhler; E Keller
Journal:  Clin Pharmacokinet       Date:  1993-05       Impact factor: 6.447

Review 3.  Pharmacokinetics of drugs used in critically ill adults.

Authors:  B M Power; A M Forbes; P V van Heerden; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

4.  Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.

Authors:  Douglas N Fish; Isaac Teitelbaum; Edward Abraham
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

5.  Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.

Authors:  I Tegeder; F Bremer; R Oelkers; H Schobel; J Schüttler; K Brune; G Geisslinger
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics during continuous haemofiltration.

Authors:  F Bressolle; J M Kinowski; J E de la Coussaye; N Wynn; J J Eledjam; M Galtier
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

Review 7.  A review of continuous renal replacement therapy.

Authors:  C G Flynn
Journal:  Ir J Med Sci       Date:  1994-07       Impact factor: 1.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.